← Leaderboards
Sameek Roychowdhury
Ohio State University
$3,938,152
Attributed
$3,938,152
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $635K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,938,152 · 6
By mechanism
UH3$2,875,329 · 3
UH2$1,062,823 · 3
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Peter G. Shields$24,078,159
- David P Carbone$20,647,321
- Steven K Clinton$5,749,067
- Lalit Sehgal$1,200,590
- Paul D Henion$2,990,638
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionMalignant NeoplasmsMolecular DiagnosticsClinical TrialsAdvanced Malignant NeoplasmEnrollmentSensitivity And SpecificityReproducibilityValidationCancer GenomicsTumorSolid NeoplasmGenesTechnologyProspectiveEvaluationPatient CareSamplingPerformanceCancer PatientMutationBaseDna SequencingDiagnostic Tests
Grant awards (13)
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers$326,741
UH3 · FY2025 · CA · contact PI
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers$310,411
UH3 · FY2024 · CA · contact PI
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers$320,278
UH3 · FY2023 · CA · contact PI
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers$114,726
UH2 · FY2022 · CA · contact PI
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility$314,062
UH3 · FY2021 · CA · contact PI
Liquid Biopsy for Rapid Detection and Real Time Monitoring of FGFR-altered Cancers$242,424
UH2 · FY2021 · CA · contact PI
Assay Validation of Targeted RNA sequencing to Detect Kinase Gene Fusions$317,824
UH3 · FY2020 · CA · contact PI
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility$317,179
UH3 · FY2020 · CA · contact PI
Assay Validation of Targeted RNA sequencing to Detect Kinase Gene Fusions$313,985
UH3 · FY2019 · CA · contact PI
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility$310,771
UH3 · FY2019 · CA · contact PI
Assay Validation of Targeted RNA sequencing to Detect Kinase Gene Fusions$344,078
UH3 · FY2018 · CA · contact PI
Detection of microsatellite instability biomarkers for therapeutic clinical trial eligibility$354,168
UH2 · FY2017 · CA · contact PI
Assay Validation of Targeted RNA sequencing to Detect Kinase Gene Fusions$351,505
UH2 · FY2016 · CA · contact PI